Cargando…

Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents

Cyclophilin A (CypA) is linked to diverse human diseases including viral infections. With the worldwide emergence of severe acute respiratory coronavirus 2 (SARS-CoV-2), drug repurposing has been highlighted as a strategy with the potential to speed up antiviral development. Because CypA acts as a p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Jinhe, Lee, Myoung Kyu, Jang, Yejin, Cho, Won-Jea, Kim, Meehyein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2022
Materias:	Keynote (Green)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123807/ https://www.ncbi.nlm.nih.gov/pubmed/35609743 http://dx.doi.org/10.1016/j.drudis.2022.05.016

Ejemplares similares

Advances in the computational landscape for repurposed drugs against COVID-19
por: Aronskyy, Illya, et al.
Publicado: (2021)

Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods
por: Choudhury, Chinmayee, et al.
Publicado: (2022)

The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects
por: Qiu, Tingting, et al.
Publicado: (2021)

Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
por: Chavda, Vivek P., et al.
Publicado: (2021)

AI-based language models powering drug discovery and development
por: Liu, Zhichao, et al.
Publicado: (2021)

Recent insights into viral infections as a trigger and accelerator in alzheimer's disease
por: De Vlieger, Lize, et al.
Publicado: (2022)

Antiviral Activity of Isoquinolone Derivatives against Influenza Viruses and Their Cytotoxicity
por: Jang, Yejin, et al.
Publicado: (2021)

Cyclophilin inhibitors as antiviral agents
por: Peel, Michael, et al.
Publicado: (2013)

Advances in the development of entry inhibitors for sialic-acid-targeting viruses
por: Heida, Rick, et al.
Publicado: (2021)

Drug repurposing for new, efficient, broad spectrum antivirals
por: García-Serradilla, Moisés, et al.
Publicado: (2019)

Broad-spectrum antiviral agents
por: Zhu, Jun-Da, et al.
Publicado: (2015)

Building Power Between Polarities: On the Space-in-Between
por: Ventres, William B.
Publicado: (2016)

Having seen it all: my vision of atrial fibrillation treatment in 2022
por: Cox, James L
Publicado: (2018)

COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
por: Kronenberger, Thales, et al.
Publicado: (2023)

Keynotes
Publicado: (2023)

Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy
por: Hicks, R.J.
Publicado: (2010)

Towards ethical guidelines for dealing with unsolicited patient emails and giving teleadvice in the absence of a pre-existing patient-physician relationship — systematic review and expert survey
por: Eysenbach, Gunther
Publicado: (2000)

One-pot multicomponent nitro-Mannich reaction using a heterogeneous catalyst under solvent-free conditions
por: Bosica, Giovanna, et al.
Publicado: (2018)

Computer-aided simulation and exergy analysis of TiO(2) nanoparticles production via green chemistry
por: Meramo-Hurtado, Samir, et al.
Publicado: (2019)

Den Umweltschutz immer im Fokus: Nachhaltiges Hygienemanagement in Zeiten der Pandemie
por: Dikken, Birke
Publicado: (2021)

Comparison of Antiviral Activity of Gemcitabine with 2′-Fluoro-2′-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2
por: Jang, Yejin, et al.
Publicado: (2021)

Nitazoxanide: A first-in-class broad-spectrum antiviral agent
por: Rossignol, Jean-François
Publicado: (2014)

Novel activities of safe-in-human broad-spectrum antiviral agents
por: Ianevski, Aleksandr, et al.
Publicado: (2018)

Discovery and development of safe-in-man broad-spectrum antiviral agents
por: Andersen, Petter I., et al.
Publicado: (2020)

Isatin derivatives as broad-spectrum antiviral agents: the current landscape
por: Elsaman, Tilal, et al.
Publicado: (2022)

Domestic animals as sentinels for environmental carcinogenic agents
por: Kimura, Katia Cristina, et al.
Publicado: (2013)

Broad-Spectrum Antiviral Therapeutics
por: Rider, Todd H., et al.
Publicado: (2011)

A Potent, Broad-Spectrum Antiviral Agent that Targets Viral Membranes
por: Wojcechowskyj, Jason A., et al.
Publicado: (2010)

Broad-Spectrum Antivirals and Antiviral Drug Combinations
por: Oksenych, Valentyn, et al.
Publicado: (2022)

Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2
por: Jang, Yejin, et al.
Publicado: (2021)

Cyclophilins and cyclophilin inhibitors in nidovirus replication
por: de Wilde, Adriaan H., et al.
Publicado: (2018)

Advances in biomechanics of posterior tibial tendon dysfunction and flatfoot deformity
por: Kitaoka, Harold B
Publicado: (2008)

Sailing charted seas: biomechanics and the orthopedic surgeon
por: Arangio, George A
Publicado: (2008)

The role of research in the development of athletic footwear
por: Lafortune, Mario
Publicado: (2008)

Biomechanical factors in diabetic foot disease
por: Cavanagh, PR, et al.
Publicado: (2008)

Advances in image-based biomechanics of the human ankle
por: Siegler, Sorin
Publicado: (2008)

Multiscale modelling and team science: the future of orthopaedic biomechanics
por: Viceconti, Marco
Publicado: (2008)

The Chronic Care Model as vehicle for the development of disease management in Europe
por: Spreeuwenberg, Cor
Publicado: (2008)

The meaning of integrated care: a systems approach
por: Edgren, Lars
Publicado: (2008)

Developing an ‘integrated health system’: the reform of health and social services in Quebec
por: Levine, David
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_fvblcmobluri2l01o8h1cgd9ac